Valuation : Divi's Laboratories Limited

Market Cap 2,45300Cr 2.57TCr 2.21TCr 2.07TCr 1.89TCr 3.57TCr 3.58TCr 25TCr 9.6TCr 1,23800Cr 9.63TCr 9.43TCr 4,10500Cr P/E 2027 *
75.2x
P/E 2028 * 62.4x
Enterprise Value 2,41800Cr 2.53TCr 2.18TCr 2.04TCr 1.87TCr 3.51TCr 3.53TCr 24TCr 9.46TCr 1,22000Cr 9.5TCr 9.29TCr 4,04700Cr EV / Sales 2027 *
19.2x
EV / Sales 2028 * 16.1x
Free-Float
48.01%
Yield 2027 *
0.38%
Yield 2028 * 0.42%
1 day+1.98%
1 week+7.47%
Current month+14.68%
1 month+24.43%
3 months+35.92%
6 months+44.17%
Current year+44.53%
1 week 8,457.5
Extreme 8457.5
9,270
1 month 7,795
Extreme 7795
9,270
Current year 5,647.5
Extreme 5647.5
9,270
1 year 5,636.5
Extreme 5636.5
9,270
3 years 3,295.3
Extreme 3295.3
9,270
5 years 2,730
Extreme 2730
9,270
10 years 532.65
Extreme 532.65
9,270
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap.
26/03/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/03/25 Sell 300 0.0001%
17/02/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.98%+7.47%+50.67%+154.29% 2.57TCr
-0.13%-6.44%+60.47%+112.05% 1,04700Cr
+0.85%-0.81%+52.77%+63.15% 65TCr
-1.03%-3.58%+22.87%+73.29% 45TCr
-1.46%-4.50%+37.43%+38.41% 35TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+12.29% 25TCr
-1.05%-1.57%+51.40%+68.55% 23TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.14%-0.30%+29.42%+89.10% 18TCr
Average -0.49%-1.66%+31.06%+59.36% 36.85TCr
Weighted average by Cap. -0.47%-3.38%+38.74%+66.13%

Financials

2027 *2028 *
Net sales 13TCr 131.58Cr 113.38Cr 106.3Cr 97Cr 182.81Cr 183.39Cr 1.26TCr 492.08Cr 6.35TCr 494Cr 483.25Cr 21TCr 15TCr 156.85Cr 135.15Cr 126.72Cr 115.68Cr 217.92Cr 218.61Cr 1.5TCr 586.59Cr 7.57TCr 588.88Cr 576.06Cr 25TCr
Net income 3.26TCr 34Cr 29Cr 28Cr 25Cr 47Cr 48Cr 327.44Cr 127.76Cr 1.65TCr 128.26Cr 125.46Cr 5.46TCr 3.94TCr 41Cr 36Cr 33Cr 30Cr 57Cr 57Cr 395.33Cr 154.25Cr 1.99TCr 154.85Cr 151.48Cr 6.6TCr
Net Debt -3.5TCr -37Cr -32Cr -30Cr -27Cr -51Cr -51Cr -351.02Cr -136.96Cr -1.77TCr -137.49Cr -134.5Cr -5.86TCr -4.49TCr -47Cr -40Cr -38Cr -35Cr -65Cr -65Cr -449.85Cr -175.52Cr -2.26TCr -176.2Cr -172.37Cr -7.51TCr
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
28/26/28 ₹9,239.00 +1.98% 7,73,225
27/26/27 ₹9,060.00 +0.39% 5,27,307
26/26/26 ₹9,025.00 +3.21% 7,08,128
25/26/25 ₹8,744.50 +2.92% 5,63,721
24/26/24 ₹8,496.00 -1.17% 2,51,013
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,239.00INR
Average target price
8,447.00INR
Spread / Average Target
-8.57%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock